CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 64 enrolled
Drug / intervention
Phase III group-based cardiac rehabilitationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00123617
NCT00123617Phase 2Completed
CompareCT.gov

The Impact of Cardiac Rehabilitation on Angina Frequency, Psychological Morbidity and Quality of Life in Women With Syndrome X

National Heart and Lung Institute·interventional·Posted Jul 25, 2005·Updated Apr 22, 2015

In Brief

A Phase 2 clinical trial evaluating Phase III group-based cardiac rehabilitation for Microvascular Angina. Completed, enrolled 64 participants across 1 site.

Detailed Summary

The study is designed to test the hypothesis that participation in a standard phase III group based cardiac rehabilitation programme will improve psychological morbidity, quality of life and cardiovascular risk factors, along with chest pain severity and frequency in women with cardiac syndrome X.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMicrovascular Angina
CountriesUnited Kingdom
CollaboratorsRoyal Brompton & Harefield NHS Foundation Trust

Timeline

Phase 2CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 25, 2005
Enrollment StartJan 1, 2003
Primary CompletionMay 1, 2005
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 20.9 years ago

Interventions

Phase III group-based cardiac rehabilitationprocedure

Phase III group-based cardiac rehabilitation